PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $118,999 | +71.6% | 55,868 | +198.0% | 0.00% | – |
| Q4 2022 | $69,364 | +433.6% | 18,747 | +4.0% | 0.00% | – |
| Q3 2022 | $13,000 | -88.7% | 18,025 | -87.8% | 0.00% | – |
| Q2 2022 | $115,000 | +447.6% | 147,558 | +550.4% | 0.00% | – |
| Q1 2022 | $21,000 | -84.8% | 22,689 | +32.1% | 0.00% | – |
| Q4 2021 | $138,000 | +43.8% | 17,174 | +49.6% | 0.00% | – |
| Q3 2021 | $96,000 | -90.2% | 11,482 | -92.3% | 0.00% | – |
| Q1 2021 | $982,000 | +1593.1% | 148,693 | +975.1% | 0.00% | – |
| Q4 2020 | $58,000 | 0.0% | 13,831 | +15.1% | 0.00% | – |
| Q3 2020 | $58,000 | -37.0% | 12,012 | +18.5% | 0.00% | – |
| Q2 2019 | $92,000 | – | 10,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |